Reader-Supported Notice: iHeartDogs is reader supported
Chang JY, Liu H, Zhang X, Balter P, Liao Z, Jeter M, Swisher SG , Mehran RJ, Roth JA, Komaki R
Kaufman believes that by reducing systemic inflammation, the GLP-1 agonists are getting at one of the root causes of these diseases
Bronwyn Holmes, a physician specializing in hormone optimization and cellular health, who also serves as a member of the medical advisory board at Eden
These drugs mimic the effects of a hormone called glucagon-like peptide-1, which regulates blood sugar levels by stimulating insulin secretion and reducing the production of glucagon, a hormone that increases blood sugar levels
This means the drug may not be the same each time you get it